Industry

Leverages next generation core platform to accelerate new product development that makes healthcare more affordable, predictable, and simple MORRISTOWN, N.J.–(BUSINESS WIRE)–Majesco, a global leader of cloud insurance software solutions for insurance business transformation, today announced that Cigna, a global health service company, is now using Majesco L&A and Group Core Suite on Majesco CloudInsurer® for … [Read more…]

NEW YORK–(BUSINESS WIRE)–An affiliate of The Beekman Group (“Beekman”) is pleased to announce the recapitalization of FCDG Management, LLC (“First Choice Dental,” “FCD,” or the “Company”), a leading multi-specialty dental service organization in the Greater Madison, Wisconsin market. Beekman’s investment will support FCD’s continued growth and enable the Company to deliver its unique culture and … [Read more…]

GAINESVILLE, Fla.–(BUSINESS WIRE)–Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced today first surgeries leveraging the power of the Newton™ Knee, featuring new, user-friendly instrumentation and a modernized graphical user interface. With a rich array of pre-clinical data, the Newton Knee is at the forefront of Exactech’s … [Read more…]

Aircarbon replaces traditional plastics, providing scalable approach to decarbonization, sustainability OVERLAND PARK, Kan.–(BUSINESS WIRE)–Looking to significantly expand its regenerative practice of transforming air and greenhouse gas into a biodegradable, plastic-like material called “Aircarbon,” Newlight Technologies has chosen decarbonization solutions leader Black & Veatch to design the biotechnology company’s first commercial-scale plant. Newlight uses a nature-inspired … [Read more…]

JERICHO, N.Y.–(BUSINESS WIRE)–Darby Dental Supply, one of the nation’s largest dental distributors, is proud to announce a strategic partnership with onDiem, a national on-demand staffing platform that connects dental practices with verified dentists, dental hygienists, dental assistants and front office professionals. This collaboration merges two innovators in the dental space to provide a modern solution … [Read more…]

WALTHAM, Mass.–(BUSINESS WIRE)–PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will release its second quarter 2022 financial results on Thursday, August 4, 2022 at 6:00 a.m. ET. The Company will host a conference call the same day at 8:00 a.m. ET to discuss these … [Read more…]

BOSTON–(BUSINESS WIRE)–Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company developing STAR-0215 for hereditary angioedema and focused on life-changing therapies for rare and niche allergic and immunological diseases, today announced that Jill C. Milne, Ph.D., Chief Executive Officer, will participate in a virtual fireside chat at the upcoming H.C. Wainwright 1st Annual Hereditary Angioedema Conference on Wednesday, … [Read more…]

NEW YORK & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Apertura Gene Therapy, a biotechnology company leveraging its novel platform technologies for developing genetic medicines to treat debilitating diseases, today announced the appointment of gene therapy executive Joseph La Barge as Chief Executive Officer. La Barge joins Apertura with over 20 years of experience in building and operating life-science companies. … [Read more…]

Triatomic Capital’s Jeff Huber to Join Board of Directors with this Funding BOSTON–(BUSINESS WIRE)–Manifold Bio, a next-generation protein therapeutics company pioneering an in vivo biologics design platform, today announced the close of a $40 million Series A financing round led by Triatomic Capital and joined by new investors Section 32, FPV Ventures, Horizons Ventures, and … [Read more…]

RADNOR, Pa.–(BUSINESS WIRE)–$MRNS #MarinusPharma—Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that it has entered into a definitive agreement to sell its Rare Pediatric Disease Priority Review Voucher (PRV) for $110 million. “Upon completion, the sale of the PRV will significantly strengthen … [Read more…]